News
PFE eyes Q2 earnings beat as strength in Vyndaqel and Padcev is expected to offset declines from Eliquis, Ibrance and Prevnar ...
Amazon's $4B stake in Anthropic and deep AWS integration boost enterprise AI adoption. Click here to find out how Claude ...
Eli Lilly › Great businesses have a habit of remaining so even when market volatility arises. The stock market is cyclical, ...
Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) ('Ascentage Pharma” or the 'Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, ...
Former Google CEO Eric Schmidt was among Anthropic’s first investors. He’d met Amodei through his then-girlfriend and now ...
Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra's AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to inve ...
We profile four of the finalists chosen in the emerging category for this year’s EY Entrepreneur of the Year awards ...
Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra’s AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement ...
Over 100 major companies — including MicroStrategy, Coinbase, AMD, Pfizer, and Boeing — are set to report earnings today, July 31. From crypto and AI to healthcare and industrials, here's the full ...
AbbVie (ABBV) came out with quarterly earnings of $2.97 per share, beating the Zacks Consensus Estimate of $2.89 per share. This compares to earnings of $2.65 per share a year ago. These figures are ...
Pfizer faces weak growth, sector headwinds, and pipeline uncertainty despite cost cuts and a 7% yield, weighing on sentiment.
The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results